Localization and structure of the muscarinic receptor ligand binding site. 1989

E C Hulme, and C A Curtis, and M Wheatley, and A Aitken, and A C Harris

A conserved aspartic acid residue in transmembrane helix 3 of the muscarinic acetylcholine receptors is important in binding the headgroup of muscarinic ligands. This acidic amino acid probably points into a relatively hydrophilic cavity whose walls are formed by the amphipathic transmembrane helices of the receptor. Amino acid side chains within this cavity contribute to ligand binding.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

E C Hulme, and C A Curtis, and M Wheatley, and A Aitken, and A C Harris
December 2013, Journal of medicinal chemistry,
E C Hulme, and C A Curtis, and M Wheatley, and A Aitken, and A C Harris
January 1993, Progress in brain research,
E C Hulme, and C A Curtis, and M Wheatley, and A Aitken, and A C Harris
March 1997, Steroids,
E C Hulme, and C A Curtis, and M Wheatley, and A Aitken, and A C Harris
February 1985, Journal of neurochemistry,
E C Hulme, and C A Curtis, and M Wheatley, and A Aitken, and A C Harris
September 1999, European journal of pharmacology,
E C Hulme, and C A Curtis, and M Wheatley, and A Aitken, and A C Harris
November 1988, Biochemical and biophysical research communications,
E C Hulme, and C A Curtis, and M Wheatley, and A Aitken, and A C Harris
July 2008, Molecular pharmacology,
E C Hulme, and C A Curtis, and M Wheatley, and A Aitken, and A C Harris
July 1992, Biochemical pharmacology,
E C Hulme, and C A Curtis, and M Wheatley, and A Aitken, and A C Harris
April 1996, Trends in pharmacological sciences,
E C Hulme, and C A Curtis, and M Wheatley, and A Aitken, and A C Harris
November 1994, Neuroscience,
Copied contents to your clipboard!